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ABSTRACT z-potentials of entities such as cells and synaptosomes have been determined, but z of brain tissue has never been
measured. Electroosmotic ﬂow, and the resulting transport of neuroactive substances, would result from naturally occurring and
experimentally or clinically induced electric ﬁelds if z is signiﬁcant.We have developed a simplemethod for determining z in tissue.
An electric ﬁeld applied across a rat organotypic hippocampal slice culture (OHSC) drives ﬂuorescent molecules through the
tissue by both electroosmotic ﬂow and electrophoresis. Fluorescence microscopy is used to determine each molecule’s velocity.
Independently, capillary electrophoresis is used to measure the molecules’ electrophoretic mobilities. The experiment yields
z-potential and average tissue tortuosity. The z-potential of OHSCs is 226 2 mV, and the average tortuosity is 1.836 0.06. In
a reﬁned experiment, z-potential is measured in various subregions. The z-potentials of the CA1 stratum pyramidale, CA3 stratum
pyramidal, and dentate gyrus are 25.1 6 1.6 mV, 20.3 6 1.7 mV, and 25.4 6 1.0 mV, respectively. Simple dimensional
arguments show that electroosmotic ﬂow is potentially as important as diffusion in molecular transport.
INTRODUCTION
An understanding of brain function, especially extracellular
transport, requires a quantitative understanding of the phys-
icochemical properties of the extracellular space. Diffusion
in the extracellular space of the brain and slice preparations
is fairly well understood. Nicholson (1,2) and Sykova (3)
measured the transport of tetramethylammonium ion (TMA1)
and polymers to reveal the details of extracellular diffusion.
Other methods such as cortical surface photobleaching (4),
magnetic resonance (5–8), integrative optical imaging (9),
and dual-probe microdialysis (10,11) have been used to
evaluate the diffusive transport of markers and biomolecules
as well as water in living brain tissue. A detailed under-
standing of variations in diffusion caused by changes in the
extracellular volume fraction has led to applications of these
techniques in assessing, e.g., edema (4). The dimensions of
the intercellular space have been determined by measuring
particle diffusion rates (12). Tortuosity has a large effect on
transport rates in heterogeneous media. Tortuosities vary de-
pending on the local geometry of the tissue (13,14). In ad-
dition, certain brain regions are anisotropic (15), leading to
a valuable method in magnetic resonance imaging called
‘‘diffusion tensor imaging’’ (5,8). We conclude that there is a
rather ﬁrm understanding of diffusive transport in the brain,
which is critical for understanding extrasynaptic (paracrine or
volume) transmission (16,17) and neuronal development (18)
as well as for making inferences from measurements (19,20).
On the other hand, there is less known about electrically
mediated transport in the brain. Electric ﬁelds and currents in
heterogeneous media create a ﬂuid ﬂow, called electroos-
motic (EO) ﬂow, by virtue of the ﬁeld’s motivating force on
the mobile counterions to ﬁxed charges on surfaces or im-
mobile macromolecules in the extracellular space. The ﬁxed
charges create a z-potential, the potential at the shear plane
between a charged surface and a moving electrolyte solution
(21). The magnitude of the z-potential controls the mag-
nitude of the EO ﬂow. The z-potential in brain tissue is a
consequence of cell-surface functional groups, such as phos-
pholipids, proteins, and carbohydrates, as well as ﬁxed com-
ponents of the extracellular matrix.
The focus of this work is to create and apply a method for
the determination of the z-potential in nervous tissue. In the
paragraphs below, we justify the need to understand this
currently undetermined parameter of brain tissue and dem-
onstrate how a method similar to electrophoresis can be used.
Certainly, electric ﬁelds occur naturally in brain. Recently,
Savtchenko et al. showed how the electrical ﬁeld created in
the synapse during ion-channel opening can inﬂuence mo-
lecular transport in the synapse, normally viewed as occur-
ring by diffusion (22). Several clinical techniques, such as
transcranial direct current stimulation (23–26) and magnetic
stimulation (27–30), also create electric ﬁelds in brain (31).
These treatments are effective in depression (25,28), stroke
(24), and other diseases. Electric ﬁelds are also used in sei-
zure control (32). In research laboratories, electric ﬁelds are
applied to brain tissue to direct neuronal growth (33), to
perform iontophoresis in the brain (34), to carry out elec-
troporation in brain (35) and embryos (36,37), and for
transnasal delivery of a charged peptide (by an electric ﬁeld
created between the nasal cavity and the back of the head
(38)). As far as we are aware, EO ﬂow is largely overlooked
in these endeavors.
EO ﬂow and/or z-potential have been measured in some
biologically relevant matrices by a variety of techniques.
EO ﬂow is knowingly created in transdermal iontophoresis
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(39–45). EO dewatering of tumors also depends on the ex-
istence of a z-potential within tissues (33,46). Outside the
ﬁelds of transdermal iontophoresis and transdermal sampling
(reverse iontophoresis (44,47)), measurements of z-potential,
or EO mobility, are rare in biological systems. Values of
z-potential have been reported for isolated cells using electro-
phoresis (48), microelectrophoresis (49), and microcapillary
electrophoresis on a chip (50). Electrophoretic methods have
also been applied to bone particles (51) as well as isolated
nuclei (52), vesicles (53), and synaptosomes (54) from brain
tissue. Measurements of transport through tissue, such as skin
that can act as a ﬁlm separating two liquid phases, are based
on quantitative determination of the ﬂux of a solute from a
‘‘source’’ phase to a ‘‘receiving’’ phase. Similarly, EO mo-
bility in plant tissues (55) can be made this way. Alternative
measurements using an oscillating electric potential (56) or
scanning electrochemical microscopy on individual skin pores
are also used (45). None of these methods is suited to whole
brain, acute brain slices, or slice cultures.
At a more fundamental level, knowing the z-potential in
intact tissue is vital to understanding molecular movement
between cells. Electroosmosis has been proposed as a con-
tributor to learning and memory (57). Even local electric
ﬁelds, such as those that materialize during epileptic seizures,
may generate ﬂuid motion. In tissues other than brain, i.e.,
lung (58) and epithelial tissue (59), naturally occurring po-
tential gradients are thought to drive ﬂuid ﬂow. A mathe-
matical theory, including double layer overlap and coupling
of mechanical and electrical forces, has been applied to
glycogen-containing cartilage models (60).
We conclude that EO phenomena have been studied in
tissues where it clearly must contribute to the observed phe-
nomena, e.g., skin (iontophoretic drug delivery and sam-
pling) and bone (stimulated bone growth). However, there is
virtually no understanding qualitatively and certainly no un-
derstanding quantitatively of the z-potential in nervous tissue.
We have developed a method to measure EO mobility and
thus z-potential as well as average tortuosity in organotypic
slice cultures of the rat (61). The velocities of ﬂuorescent
molecules aremeasured in the cultured tissue under an applied
ﬁeld. Data analysis is guided by simple theory, shown below.
THEORY
Consider a set of ﬂuorescent molecules with various electro-
phoretic mobilities. A spot consisting of a single ﬂuorophore is
placed in an OHSC. In an electric ﬁeld, the ﬂuorophore will
move at an observed velocity, vobs, as given in Eq. 1, which can
be inferred from Boyack and Giddings (62) and Rathore et al.
(63) (le¼ tortuosity; veo¼ EO velocity; vep¼ electrophoretic
velocity):
vobs ¼ 1=l2e
 ðveo1 vepÞ: (1)
We assume that veo and vep experience the same tortuosity.
Note that the deﬁnition of tortuosity is consistent with
Boyack and Giddings (62) and Rathore et al. (63). We denote
that the tortuosity inﬂuences an electrokinetic process with
the subscript ‘‘e’’. This tortuosity may not be the same as the
ratio of free and effective diffusion coefﬁcients (see Discus-
sion for more detail). Equations 2 and 3 (21,63) deﬁne the
velocities as the products of mobilities, m, and a ﬁeld, E.
vep ¼ mepE (2)
veo ¼ ej
h
E ¼ meoE (3)
Equation 3 shows that meo is a function of z, the z-potential,
the medium’s viscosity (h), and permittivity (e). Values of
mep can be determined for each ﬂuorophore independently in
HBSS by CE; thus they are known quantities. The observed
mobility, mobs, can be deﬁned as Eq. 4 for an individual
ﬂuorescent species. If the tortuosity is not dependent on the
ﬂuorophore, a plot of mobs versus mep will yield a straight line
with a slope of Æ1=l2eæ; where the brackets indicate ‘‘aver-
age’’. The intercept provides meo, and thus z.
mobs ¼
vobs
E
¼ 1=l2e
 
mep 
ej
h
 
¼ 1=l2e
 ðmep1meoÞ (4)
Another approach involves the use of two molecules simul-
taneously (molecule 1 and molecule 2). Each molecule is
independently described by Eq. 5. Thus the term l2e=E can be
eliminated, as shown in Eqs. 6 and 7 (subscripts 1 and 2 refer
to individual molecules).
meo ¼
vobsl
2
e
E
 mep (5)
meo ¼
vobs1
vobs2
 
ðmeo1mep2Þ  mep1 (6)
meo ¼
vobs1
vobs2
 
mep2  mep1
1 vobs1
vobs2
  ¼ ej
h
(7)
MATERIALS AND METHODS
Chemicals and solutions
The following materials were purchased from Sigma (St. Louis, MO) and
were used as received. The culture medium contained basal medium Eagle
(50%), Earl’s basal salt solution (20%), horse serum (23%), penicillin/
streptomycin (25 units/ml), L-glutamine (1mM), andD-(1)-glucose (7.5 g/L).
The culture medium was stored in a refrigerator and warmed to 37C
before use.Gey’sBalancedSalt solution (GBSS)was supplementedwith 27.5
mM D-(1)-glucose and 2.7 mM MgSO4. The following solutions were
prepared with 18 MV puriﬁed water from a Millipore Synthesis A10 system
(Millipore, Billerica, MA): NaOH solutions, HEPES-buffered salt solution
(HBSS) containing (mM): 143.4 NaCl, 5 HEPES, 5.4 KCl, 1.2 MgSO4, 1.2
NaH2PO4, 2.0 CaCl2, and 10 D-(1)-glucose. HBSS was ﬁltered, stored in a
refrigerator, and warmed to 37C before use. Approximately 3% agarose
type-VII in HBSS ﬁlled the apparatus shown in Fig. 1.
Each of the ﬂuorescent molecules was diluted with HBSS, ﬁltered, and
frozen until use. The concentration of each probe was empirically determined
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to accommodate its intensity under experimental conditions. See Table S1
in Supplementary Material, Data S1 for the concentrations. Fluorescent
dextran conjugates 1–6 were purchased from Invitrogen/Molecular Probes
(Eugene, OR). 7 and 8 were obtained from Sigma (Table 1).
Instrumentation
Capillary electrophoresis
Electrophoretic mobilities in HBSS were determined using an ISCO Capil-
lary Electropherograph (Lincoln, NE) with vacuum injection (10 s, 0.5 psi)
and ultraviolet-visible absorbance detection. A section of the polyimide
coating was removed with a low-temperature ﬂame to create the window.
New capillaries were ﬂushed with base overnight. Before each series of
experiments, capillaries were ﬂushed with 200 mL of distilled, deionized
water, followed by the same volume of the running buffer. The high voltage
was then applied to the capillary, and the system equilibrated for 5–20 min.
All injections included rhodamine B as the EO ﬂow marker and were per-
formed at ambient temperature (23C 6 2C). The EO ﬂow marker is a
neutral molecule with a mobility equal to zero. Its velocity in a capillary
electrophoresis (CE) experiment is the electroosmic velocity.
CE measurements of mobilities were performed using 360-mm outside
diameter (OD) capillaries with inner diameters (IDs) of 40 or 50 mm. The
total capillary length ranged from 50.3 to 118.4 cm, with 25.5–48.1 cm from
the injection end to the detection window using9.0 to22.1 kV. Detection
was at 495, 505, or 595 nm. See Table S2 for the parameters used for each
particular molecule.
Apparatus for tissue experiments
The apparatus in Fig. 1 was manufactured from Lucite locally. A 40-V direct
current power supply (Heath, Benton Harbor, MI) applies a low homoge-
neous ﬁeld (;22 V/cm at the tissue) across the organotypic hippocampal
slice culture (OHSC). TwoGoodfellow (Cambridge, England) tubular platinum
electrodes (1 mm OD, 0.1 mm wall thickness, and ;3.8 cm long) were
placed into separate cylindrical reservoirs (19 mm in diameter and 12 mm
deep) separated by a narrow rectangular channel 44 mm in length. These
reservoirs are not shown in Fig. 1. The OHSC remained on the insert mem-
brane during the measurements. Electrical contact between the OHSC and
the electrodes was made by agarose-containing HBSS.
Ag/AgCl electrodes
A pair of in-house fabricated Ag/AgCl microelectrodes measured the po-
tential gradient in the tissue. The electrodes were made from 0.1-mm-
diameter silver wire from JMC (Hertfordshire, England). Two sets were
made: one spaced 0.80–0.90 mm apart and another spaced 0.35–0.40 mm
apart. Distances were determined using a scale bar and micrographic images
of each individual experiment.
Injection capillary
A 250 mm (ID) fused-silica capillary was pulled to a tip (;12 mmOD) using
a P-2000 capillary puller from Sutter (Novato, CA). A Sutter MP-285 mi-
cromanipulator lowered the capillary into the OHSC. The distal end of the
capillary was attached to a Harvard PHD4400Hpsi syringe pump (Holliston,
MA) with a 50 mL Hamilton Gastight syringe (Reno, NV). The pump de-
livered ﬂuid at a ﬂow rate of 120 nL/min for ;1 s.
Imaging
An inverted ﬂuorescent microscope (Model IX71) with a U Plan Apo 43
objective lens (both from Olympus, Melville, NY) imaged the tissue ex-
periment using a charge-coupled device camera (ORCA-285 Hamamatsu,
Hamamatsu City, Japan). Depending on the ﬂuorescent properties, an ap-
propriate cube was chosen. The Olympus ﬂuorescence cubes are a wide in-
terference ﬁlter blue cube (exciter 460–495 nm, dichromatic mirror 505 nm,
emitter 510–550 nm interference ﬁlter) and a wide interference ﬁlter green
cube (exciter 530–550 nm, dichromatic mirror 570 nm, emitter 575 nm in-
terference ﬁlter). A Semrock (Rochester, NY) DA/Fl/TA-3X-A Triple-band
‘‘Pinkel’’ ﬁlter set (exciter 1 387 nm, exciter 2 494 nm, exciter 3 575 nm,
dichromatic mirror: 394–414 nm, 484–504 nm, 566–586 nm, emitter: 457,
530, 628 nm) was used for multiple ﬂuorophore experiments.
Image processing and distance measurements were done with SimplePCI
6.0 software (Compix, Cranberry, PA). Images of the paired Ag/AgCl
electrodes using the microscope camera were captured daily to measure the
distance between the electrodes. The same was done for measuring IDs of
new injection capillaries.
Procedures
Hippocampal organotypic slice cultures
The Stoppini culturing method was used with small variations (61). The
procedures described here have been approved by the University of Pittsburgh
FIGURE 1 The apparatus. The OHSC and its insert membrane are placed
against the cast agarose gel. The apparatus is placed on an inverted
ﬂuorescence microscope for data acquisition. Reference electrodes measure
the ﬁeld strength near the ﬂuorophore spots.
TABLE 1 Values of mep in HBSS
Fluorescent compound mep/(10
9 m2/Vs) Mean 6 SE/(109 m2/Vs)
Alexa Fluor 568 dextran conjugate 10 kDa* (1) 1.92 60.15
BODIPY FL dextran conjugate 10 kDa* (2) 0.89 60.22
Fluorescein dextran conjugate 70 kDa* (3) 9.75 60.82
Oregon Green dextran conjugate 10 kDa* (4) 18.0 60.1
Rhodamine Green dextran conjugate 3 kDa* (5) 1.72 60.19
Texas Red dextran conjugate 70 kDa* (6) 0.55 60.19
Fluorescein sodium salt (7) 26.3 60.3
Tris(2,29-bipyridine)ruthenium (8) 26.0 60.0
*Dextran conjugate.
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IACUC. The hippocampi were dissected bilaterally from decapitated, 7-day
postnatal Sprague-Dawley albino rats. The hippocampi were cut transversely
into 500-mm-thick slices with a McIlwain tissue chopper from The Mickle
Laboratory Engineering (Surrey, England). The cultures were placed on
Millicell membrane inserts from Millipore and incubated over culture me-
dium at 95% air/5% CO2. Cultures may be incubated for up to 2 weeks. All
data reported here are from cultures incubated for 3–7 days. The mean slice
thickness in this time period was 148 mm, consistent with other reports
(61,64,65). On the day of the experiment, 37C GBSS replaced culture
medium, followed by 30 min of tissue incubation. This procedure was re-
peated once more. Lastly, 37C HBSS replaced GBSS before the experiment.
Using an X-Acto knife, the insert membrane was cut to liberate the tissue
and the insert membrane under it from excess insert membrane. Edges of the
insert were left to allow moving the OHSC into the apparatus without
damage, as in Fig. 1. A portion of the agarose gel was cut away to make room
for the OHSC. The OHSC was placed into the apparatus in such a way that
the insert edges are under the agarose but the slice is adjacent to the gel, as
show schematically in Fig. 1.
z-potential determination
The tip of the injection capillary, preloaded with ﬂuorescent probe-con-
taining solution at room temperature, was inserted approximately midway
(;75 mm) into the OHSC with the aid of a micromanipulator. The pump
delivered ;2 nL of the ﬂuorescent material. On occasion, placing the cap-
illary into tissue alone delivered enough ﬂuorophore by capillary effects. The
capillary was carefully pulled out of the slice, and the microelectrodes were
placed in the tissue. Before the voltage supply is turned on, the exposure time
is set using autoexposure and the SimplePCI 6.0 software begins recording
the ﬂuorescence. The voltage supply was switched on, applying ;22 V/cm
through the slice. Measurements of electric ﬁeld and velocity are taken once
the electric ﬁeld stabilizes (a few seconds). Images were acquired once per
second.Movement of a ﬂuorophore toward the cathode is deﬁned as positive.
Two-ﬂuorophore experiments
Two sets of paired molecules were used. One set was 1 and 7, and the other
set was 3 and 8. To measure the velocity of each ﬂuorophore simultaneously,
the ‘‘Pinkel’’ ﬁlter set was used. At ﬁrst, each ﬂuorophore is injected into an
OHSC separately. The separate exposure times are set using the autoexpo-
sure command for a two-color image in the SimplePCI 6.0 software. A
mixture of the paired ﬂuorophores is then injected into a different OHSC for
measurement.
RESULTS
Table 1 shows the CE-determined mobilities for each ﬂuo-
rophore. Fig. 2 shows images from an experiment in an
OHSC. The OHSC received three injections, labeled A, B,
and C. A and C are injections into the insert membrane, and B
is in the OHSC. We ﬁnd that ﬂuorophore injected into the
insert membrane is immobile regardless of the selected ﬂuo-
rophore or applied ﬁeld. Each point in Fig. 2 (1–8) functions
as an intensity detector. We measure the intensity at each
point as a function of time (Fig. 3).
vobs corresponds to the slope of a plot of the relative po-
sitions of the detection points versus the peak times (Fig. 3,
inset). This plot routinely yields straight lines, indicating that
ﬂuorophore velocity and electric ﬁeld are constant during the
experiment. Dividing the velocity by the applied electric
ﬁeld, measured using an Ag/AgCl reference electrode pair
placed in the tissue, yields the observed mobility (mobs) as
shown in Eq. 4.
Fig. 4 is a plot ofmobs versusmep. The errors are the mean6
SE and are also given in Table 2. Analysis of the results (linear
regression) according to Eq. 4 leads to Eq. 8.
mobs= m
2
=Vs
  ¼ 0:30ð60:02Þmep1 5:2ð60:3Þ3 109 (8)
The slope of 0.306 0.02 is equal to the inverse square of the
average tortuosity. The average (electrokinetic) tortuosity is
therefore 1.836 0.06. The z-potential in the OHSC is226
2 mV.
The z-potential described above is an average from all
areas of the OHSC in the direction of the line, as indicated in
Fig. 5 (approximately along the medial-lateral axis). As noted
in the introduction, there are regional differences in the hip-
pocampus. Are there different z-potentials in different re-
gions? A micrograph of an OHSC (Fig. 5) shows areas
interrogated with the two-ﬂuorophore experiments; 1 was
paired with 7 in 41 experimental runs. The 3 and 8 pair was
run twice.
The CA1 stratum pyramidale, CA3 stratum pyramidale,
and dentate gyrus have z-potentials, respectively, of (mV)
25.1 6 1.7 (n ¼ 12), 20.3 6 1.6 (n ¼ 14), and 25.4 6
1.0 (n ¼ 34). Analysis of variance reveals that there is a
signiﬁcant difference among the regions (p, 0.05), which is
accounted for by the difference between the value in CA3 and
the other two.
DISCUSSION
Analysis of the method
CE measures the electrophoretic mobility of the ﬂuorophores
used in the tissue experiment. As a result of the high electro-
lyte concentration, we had to modify typical CE procedures.
FIGURE 2 Alexa Fluor 568 10 kDa dextran
conjugate was injected into the insert membrane
(injections A and C) and into the tissue culture
(injection B). After applying the potential, injec-
tion B migrates toward the cathode, as shown in
the sequence of images. Injections A and C remain
in place despite the electric ﬁeld. Intensities are
measured at points 1–8 as a function of time. The
smaller injections A and C are ;135 mm in
diameter. Injection B is ;500 mm in diameter.
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To minimize the effect of thermal gradients, a narrow (40mm
ID) and long (;100 cm) capillary replaces the more common
75 mm ID, 50-cm-long capillary. With the longer, narrower
capillary, peak shape is good.
Labeled dextrans (Data S1) are the most successful cate-
gory of ﬂuorophores for our experiments. Dextran ﬂuo-
rophores are easily visible with a ﬂuorescence microscope;
they haveminimal ‘‘nonspeciﬁc’’ binding (1,66,67); and their
CE results are unambiguous. Apparently, the ﬂuorescent
labels on each of the dextrans account for their different
mobilities; 7 and 8, both nondextran conjugate ﬂuorophores,
also have similar characteristics, thus are acceptable for our
study. Several other ﬂuorophores, on the other hand, do not
meet the necessary criteria (Data S1).
Although an in vivo model preserves the true environment
of tissue, several advantages make the OHSC the optimal
model for our purposes. We can easily track temporal
changes in tissue slice cultures using an inverted microscope.
Moreover, tissue slices are viable models because the cyto-
architecture and electrophysiology are preserved after ex-
plantation (1,61–63,68–70). Additionally, cultured slices are
easier to manipulate than acute slices.
A tissue culture is easily placed in the apparatus as shown
in Fig. 1. We use the apparatus to apply a potential gradient
along the tissue by providing electrical contact through aga-
rose gel. The design of the apparatus is such that the tissue
sits in a narrow channel between two reservoirs, thus in-
creasing the resistance in the channel. The increased resis-
tance ampliﬁes the electric ﬁeld. The change in depth from
the agarose gel to the OHSC further concentrates the ﬁeld in
the tissue. Thus, the ﬁeld is largest within the OHSC. Ap-
plying a large ﬁeld through a tissue can alter its permeability
or electroporate the cells (71). Typical ﬁelds in electropora-
tion,;1 kV/cm, are;45 times larger than the ﬁeld strengths
applied in the apparatus. To isolate the experiment from any
electrolysis products created at the platinum electrodes, the
electrodes are placed in deep reservoirs far from the tissue.
Early designs of the apparatus had much smaller reservoirs.
pH-responsive ﬂuorophore experiments showed that elec-
trolysis products moved into the channel within 6 min and
FIGURE 3 The intensity proﬁles recorded at each of the eight detection
points on the cathodic side of the original injection. Inset: The relative
position of the detection points (1–8) in Fig. 2 are plotted as a function of the
times of the peak maxima (inset). The linearity implies that the ﬂuorophore’s
velocity is constant throughout the experiment.
FIGURE 4 The effective mobility in tissue as a function of the electro-
phoretic mobility. The line is the best ﬁt to all of the data (linear regression).
The labels at each point identify the identity of the ﬂuorophore (see Table 1)
and its molecular mass.
TABLE 2 A summary of the average observed mobilities in
tissue and their mean 6 SE
Fluorophore mobs/(10
9 m2/Vs) Mean 6 SE/(109 m2/Vs) n
1 6.46 60.67 58
2 4.09 60.39 19
3 1.85 60.24 22
4 0* - 14
5 4.31 60.35 13
6 3.66 60.71 12
7 3.15 60.39 55
8 10.3 61.3 10
*No measureable movement. n is the number of experimental runs for that
speciﬁc ﬂuorophore.
FIGURE 5 A micrograph of an organotypic hippocampal slice culture.
The circumscribed areas represent the portions of the CA1, CA3, and dentate
gyrus (DG) investigated. The horizontal line represents the direction in
which the tortuosity is measured in the single-ﬂuorophore experiment.
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altered the properties of the gel. The same pH-responsive
ﬂuorophore experiments repeated in the current apparatus
design show that the electrolysis products remain in the
reservoirs for well over 30 min. This provides plenty of time
to run the tissue experiment.
To preserve the integrity of the tissue while injecting ﬂuo-
rescent material, several provisions are taken. Primarily, the
injection capillary is pulled to a 12 mm OD tip to minimize
tissue damage. A micromanipulator allows control over the
depth of the injection. The injection capillary delivers;2 nL
of ﬂuorophore into the tissue to maintain the microenviron-
ment. There is no obvious damage to the tissue as a result of
injection.
The membrane insert has completely different properties
than tissue. The membrane itself is made of poly(tetraﬂuoro-
ethene) with a proprietary hydrophilic surface modiﬁcation.
When ﬂuorescent material is injected into the membrane, it
appears to stay in place (Fig. 2, injections A and C). There-
fore, ﬂuorescent compounds moving in the visual ﬁeld are in
fact injected into the tissue and not into the insert membrane.
Analysis of the results
The measured z-potential is226 2 mV. The value is in the
range of isolated biological materials, such as mouse N-18
cells measured by a microelectrophoretic apparatus with a
z-potential of 15 mV (49,72), chromafﬁn granules, 14.4
mV (53), and rat brain synaptosomes using particle electro-
phoresis, 11.8 mV (54). Theoretical calculations deter-
mined a cartilage model containing glycogen to have a
z-potential of 27 mV (60). Ranck estimated the z-potential
in brain to be 15 mV based on the constituents of the
plasma membranes of neurons and glial cells (57).
The z-potential determined using two ﬂuorophores si-
multaneously is independent of the average tortuosity factor
and ﬁeld (Eq. 7). The mean z-potential from the simultaneous
ﬂuorophore experiments is essentially the same as that in the
single ﬂuorophore experiments. We infer from this either of
two things: the values of the ﬁeld and tortuosity from the
single-ﬂuorophore experiments are correct, or there is a for-
tuitous cancellation of deterministic errors. We view the latter
conclusion as a remote possibility. Thus, the two-ﬂuorophore
experiment further validates the experimental method.
The two-ﬂuorophore method is capable of distinguishing
small differences in z-potential between different structures
in the brain: CA1 (25.1 6 1.7 mV), CA3 (20.3 6 1.6
mV), and dentate gyrus (25.4 6 1.0 mV). The CA1 and
dentate gyrus regions have statistically the same z-potential
at a 95% conﬁdence level. However, a single-factor analysis
of variance analysis reveals that there is a statistical differ-
ence among the three areas (p, 0.05). It is interesting to note
that these regions have different vulnerabilities to excito-
toxicity correlated with the differences in z-potential. The
CA1 and dentate gyrus regions are more susceptible to
N-methyl-D-aspartic acid excitotoxicity than the CA3 region
(73). Perhaps the z-potential differences between the regions
take part in mechanistic differences.
The experiments yield an average (electrokinetic) tortu-
osity. Tortuosity in the neurochemical context as determined
through diffusion measurements is deﬁned as lD ¼
(D=Dobs)
1=2 where D is the molecular diffusion coefﬁcient in
an unobstructed medium, Dobs is the observed diffusion
coefﬁcient, and the subscript D denotes diffusion. It is
noteworthy that tortuosity inﬂuences ﬂuid ﬂow (21) and
electrophoresis (64) through porous media. Boyack considers
two contributions to tortuosity in electrophoresis: one is
purely geometrical—the ratio of the actual distance that a
molecule travels in its path around obstacles to get from point
A to point B to the straight line distance between A and
B—whereas the other is related to the ampliﬁcation of the
electric ﬁeld in narrow conduits. Similarly, tortuosity as
measured by diffusion is related to a geometrical component
and other factors, e.g., local viscosity (74). Thus measure-
ments made by diffusion and by electrokinetic experiments
may not yield the same result.
In the development of the data treatment (Eq. 4), we as-
sumed that the tortuosity (as determined by electrokinetic
experiments) is independent of brain region and ﬂuorophore
size and charge. In fact, there is a dependence of tortuosity (as
measured by diffusion) on molecular mass and type of poly-
mer (in acute cortical slices) (1,75,76). Using a small probe
molecule, TMA1, differences in tortuosity (as measured by
diffusion) in different regions of the hippocampus have been
found (13,15,77). In cortical slices, Nicholson found that the
range of tortuosities for ﬂuorescein-conjugated dextrans in
the same molecular mass range that we used (3–70 kDa) was
from 1.77 to 2.25 (76). Thus, to the degree that the tortuos-
ities measured electrokinetically and diffusionally are the
same, our measured tortuosity has to be considered an
average over the molecular masses and the brain regions
studied.
If there is a correlation between the observed mobility and
ﬂuorescent species molecular mass, molecular mass effects
on tortuosity may lead to a deterministic error in z. If there is
no correlation, differences in tortuosity will add to the error in
z but will not affect its magnitude. From Fig. 4, it can be seen
that there is no signiﬁcant pattern of deviation from the line
due to molecular mass. The correlation coefﬁcient of the
molecular mass and electrophoretic mobility (data in Table 1)
is 0.07, demonstrating the lack of correlation. Thus, the
assumption of an average tortuosity adds to the error in z but
does not inﬂuence the measured magnitude of z. Further-
more, recall that the two-ﬂuorophore experiment yields a
result that is independent of tortuosity (if it is again assumed
that one tortuosity applies to both dyes). The average z-po-
tential from these results, as mentioned above, is indistin-
guishable from the value determined from Eq. 4. Thus,
although the assumptions about the tortuosity certainly must
add to the uncertainty, they are apparently not inﬂuencing the
result for z-potential.
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Potential applications and implications
A plot of mobs versus mep (e.g., Fig. 4) relates an easily
measured quantity, mep, to information about how fast a
molecule moves in the brain. This is useful in the context of
experimental procedures like iontophoresis. The mobs for a
solute dictates whether it will move into or away from an
iontophoresis capillary. A neutral molecule, for example, has
a mep of 0 m
2/Vs. By applying Eq. 8, the mobs is expected to
be ;5.2 3 1010 m2/Vs. Therefore, in the OHSC and with
the proviso that the iontophoresis capillary z-potential
matches the tissue z-potential, a neutral compound would
move toward the cathode. To eject a neutral compound ion-
tophoretically, it must be in the anodic chamber.
It is instructive to consider under what conditions EO ﬂow
contributes to the transport of a neutral molecule by com-
paring the magnitudes of EO velocity and diffusive velocity.
This is done with the Peclet number, Pe. The Peclet number is
the ratio of the time required to diffuse a characteristic dis-
tance a, (;a2/D), to the time required to move with the ﬂuid
ﬂowing at velocity v over the same distance, a (a/v).
Pe ¼ va
D
(9)
For a neutral solute, the Smoluchowski equation (Eq. 3) for z
with the Stokes-Einstein equation for D yields the following
Peclet number:
Pe ¼ 6praezE
kT
: (10)
In Eq. 10, r is the radius of the presumed spherical solute, k is
Boltzmann’s constant, and T is temperature. If we assume
that tortuosity inﬂuences diffusion and migration to the same
degree, it does not appear in Pe. The ﬁeld at which diffusive
and electrokinetic velocities are equal, Ec, is thus
Ec ¼ kT
6praez
: (11)
Finally, equating Ec with a critical voltage difference over the
characteristic length, DVc/a, the critical voltage is given as
Eq. 12:
Vc ¼ kT
6prez
: (12)
Note that the characteristic distance divides out. We can use a
correlation (78) to relate molecular radius and molecular
mass. For a 1 kDa (r¼ 0.84 nm) neutral molecule, the critical
voltage is 19 mV (for the z-potential that we measured, 22
mV). For a 10 kDa neutral (r¼ 2.6 nm), the critical voltage is
only 6 mV. Clearly, this magnitude of potential difference is
plausible, leading to the conclusion that EO ﬂow may in fact
play a role in extracellular transport.
If EO ﬂow does play a role, how would it inﬂuence
charged neurotransmitters/modulators? The direction of EO
ﬂow when z is negative is the same as the electrophoretic
direction of a cation. Thus, an electric ﬁeld would drive a
cation more rapidly, and an anion less rapidly, in the presence
of EO ﬂow in comparison to the absence of EO ﬂow. It is
interesting to note that the inﬂuence of dopamine, a cation, is
felt outside the synapse. Further, its local concentration and
concentration dynamics are important in its actions (79,80).
The presence of an electric ﬁeld would cause dopamine to
move relatively rapidly. In vertebrate brain, the anionic
amino acid glutamate is responsible for fast neurotransmis-
sion. Unrestricted diffusion of glutamate over larger areas
may cause synchronous activation of neurons and epilepsy.
Thus this type of transmission has to be tightly localized to
the individual synapse from which glutamate is released. The
main system to regulate this process is reuptake. However, it
is worth noting that any electric ﬁeld that exists would have
very little impact on glutamate’s motion—its electrophoretic
velocity and the extracellular ﬂuid’s EO velocity will coun-
teract each other.
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